From: Serial monitoring of LV function following chemotherapy: assessment using advanced echocardiography and cardiovascular magnetic resonance
LVEF (CMR)
(%)
LVEF
(Echo)
GLS
Baseline
71.9 ± 6.3
63.8 ± 5.7
-21.4 ± 2.6
3 months
66.7 ± 6.7 **
63.5 ± 7.2
-19.5 ± 2.0 **
12 months
65.9 ± 7.0 **
62.1 ± .9
-20.1 ± 2.6